CSL Behring donation to the Infection group in the immunocompromised pediatric patient
October 2021
CSL Behring, a pharmacist dedicated to the production and marketing of products of plasma and biotechnological origin, has signed an agreement for the donation of € 54,000 for the Research Group on Infection in the Immunocompromised Pediatric Patient of the Vall d'Hebron Institute of Research (VHIR).
The team led by Dr. Pere Soler (president of the foundation) will carry out a project that will optimize the use of immunoglobulins, a scarce resource, as a treatment in pediatric patients with primary or secondary immunodeficiencies.